Editorial Board Member - JCS
Peter Parker
ProfessorLondon Research Institute
United Kingdom
BIOGRAPHY:
Dr. Peter Parker was trained as an undergraduate in Biochemistry (BA) at Oxford and then as a post-graduate under Professor Sir Philip Randle in Clinical Biochemistry (D.Phil) at Oxford. He subsequently won an MRC Post-Doctoral Fellowship to work with Professor Sir Philip Cohen in Dundee and following this started working in the area of oncology as an ICRF (now CRUK) Fellow with Professor Mike Waterfield in London. Professor Parker has run an independent cancer research group since 1986 publishing over 300 primary research articles and reviews in the area of cancer and signal transduction.
Dr. Peter Parker has been recognised for his research contributions having been elected to the European Molecular Biology Organisation in 1995, to the Academy of Medical Sciences in 2000, he was awarded the Morton Prize in 2004 and elected to the Royal Society in 2006 and the EACS in 2011. Peter is Head of the Division of Cancer Studies at King’s College London, Deputy Director and R&D lead for the KHP Integrated Cancer Centre and is a Principal Scientist at the London Research Institute.
Dr. Peter Parker has ongoing research activities in oncology with expertise in signal transduction, molecular cell biology, biomarker research and drug discovery. Peter Parker has co-founded two biotechnology companies (co-founder of Piramed and of Symansis) and retains active links to biotech and pharma in the pursuit of delivering new interventions in the clinic.
RESEARCH INTERESTS:
Protein kinases
Protein kinase C
Signal transduction
Cancer cell biology
Other Editorial Board Members - JCS
Chunying Li
Department of Biochemistry and Molecular Biology
Wayne State University School of Medicine
United States
Ken-ichi Mukaisho
Department of Pathology
Division of Molecular Diagnostic Pathology
Shiga University of Medical Science
Japan
Yaguang Xi
Mitchell Cancer Institute
University of South Alabama
United States
Zeina Ghorab
Department of Pathology
Sunnybrook Health Sciences Centre
Canada
Tao Liu
University of New South Wales
Australia
Dong-Hua Yang
Fox Chase Cancer Center
United States
Rajkumar Vajpeyi
Laboratory Medicine and Pathobiology
University of Toronto
Canada
Dagmara McGuinness
College of Medical
Veterinary & Life Sciences
Institute of Cancer Sciences
Western Infirmary Glasgow
Scotland
Kam C. Yeung
Department of Biochemistry & Cancer Biology
University of Toledo College of Medicine
United States